MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze ALPS →
    • FindStock Picks / Stock Screener
    • Value · ALPSIntrinsic Value Calculator
    • Invest · ALPSInvestment Case
    • Hold · ALPS5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
ALPS

ALPS

Alps Group Inc

$0.32
0
 (-0.03%)
Exchange:  NASDAQ
Market Cap:  53.231M
Shares Outstanding:  162.401M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  BiotechnologyView industry performance
   
CEO:  Seng Kong Tham
Full Time Employees:  93
Address: 
The ICON, East Wing Tower, Level 18-01 & 18-02, No.1, Jalan 1/68F, Off Jalan Tun Razak
Kuala Lumpur
WP
50400
MY
Website:  https://alps-holdings.com
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
ALALPS logoALPSAlps Group Inc53.2M——-48.1%
HRHRTX logoHRTXHeron Therapeutics, Inc.56.3M——-6.8%
CNCNTB logoCNTBConnect Biopharma Holdings Limited49.7M——-191.3%
GAGANX logoGANXGain Therapeutics, Inc.49.3M——-157.8%
CRCRBU logoCRBUCaribou Biosciences, Inc.48.0M——-86.3%
TETENX logoTENXTenax Therapeutics, Inc.47.2M——-60.4%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202420252026
Revenue2,403.5523,371.0374,856.320
Gross Profit598.9301,301.2651,558.274
EBITDA-1,452.292-1,352.369-901.364
Operating Income-2,409.129-2,501.538-3,380.980
Net Income-2,304.026-2,513.573-2,008.428

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202420252026
Total Assets7,133.6379,899.5196,969.390
Total Liabilities8,249.55310,165.19510,199.391
Total Stockholders Equity-888.560-38.320-2,924.618
Total Debt961.8753,166.325559.272
Cash and Cash Equivalents318.9323,034.585607.473

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202420252026
Operating Cash Flow-1,608.785-2,575.649-2,575.649
Capital Expenditure-83.772-56.413-56.413
Free Cash Flow-1,692.557-2,632.062-2,632.062
Net Income-2,529.176-2,081.318-2,081.318
Net Change in Cash-141.535288.541288.541

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

🔒 You are currently logged out

Login

It's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
0
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
-0.68
?Enterprise Value
 (TTM)
: 
54.032M  ?EV/FCF
 (TTM)
: 
-103.77
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
0%
?ROE
 (TTM)
: 
20.73%  ?ROIC
 (TTM)
: 
-48.07%
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
-0.19
?P/B
 (TTM)
: 
-0.39  ?Current Ratio
 (TTM)
: 
0.36

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
N/AResearch AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate ALPS Intrinsic Value

Common questions about ALPS valuation

Is Alps Group Inc (ALPS) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Alps Group Inc (ALPS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is ALPS a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ALPS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is ALPS’s P/E ratio?

You can see ALPS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for ALPS?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is ALPS a good long-term investment?

Whether ALPS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Alps Group Inc

  • Alps Group Inc intrinsic value calculatorEstimate what the business is worth
  • Alps Group Inc 5-year outlookWhat has to go right, and what could go wrong
ALPS

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.03
MarketSnap

Trading Metrics:

Open: 0.32   Previous Close: 0.32
Day Low: 0.32   Day High: 0.32
Year Low: 0.23   Year High: 1.72
Price Avg 50: 0.37   Price Avg 200: 0.67
Volume: 31632   Average Volume: 104230

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

SS&C ALPS Advisors Rings NYSE Opening Bell
30-10-2026 17:31
SS&C ALPS Advisors Rings NYSE Opening Bell

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze ALPS →
    • FindStock Picks / Stock Screener
    • Value · ALPSIntrinsic Value Calculator
    • Invest · ALPSInvestment Case
    • Hold · ALPS5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read